Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system-Reference-Cited by-同舟云学术

Implication of the proprotein convertase NARC-1/PCSK9 in the development of the nervous system

Published:2006-08 Issue:3 Volume:98 Page:838-850
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J Neurochem

Author:

Poirier Steve,Prat Annik,Marcinkiewicz Edwige,Paquin Joanne,Chitramuthu Babykumari P.,Baranowski David,Cadieux Benoit,Bennett Hugh P. J.,Seidah Nabil G.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2006.03928.x/fullpdf

Reference60 articles.

1. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

2. Novel mutations of thePCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia

3. Dual regulation of the LDL receptor—Some clarity and new questions

4. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues.

5. Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The kpc-1 3′UTR facilitates dendritic transport and translation efficiency of mRNAs for dendrite arborization of a mechanosensory neuron important for male courtship;PLOS Genetics;2024-08-07

2. Proprotein convertase subtilisin/kexin type 9 deficiency in extrahepatic tissues: emerging considerations;Frontiers in Pharmacology;2024-07-30

3. Zebrafish ApoB-Containing Lipoprotein Metabolism: A Closer Look;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-05

4. Case Report: Neurological adverse events in subject with myasthenia gravis after PCSK9 inhibitor administration;Frontiers in Cardiovascular Medicine;2024-03-12

5. Targeting PCSK9 to tackle cardiovascular disease;Pharmacology & Therapeutics;2023-09